Evidence of a conjugal erythromycin resistance element in the Lyme disease spirochete Borrelia burgdorferi

International Journal of Antimicrobial Agents

Volumn 27, Issue 5, 2006, Pages 367-377

  Jackson, Charlene R ^a   Frye, Jonathan G ^a   Boylan, Julie A ^b   Gherardini, Frank C ^b  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Antimicrobial resistance; Borrelia burgdorferi; Conjugation; Erythromycin

Indexed keywords

CARBON 14; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CLINDAMYCIN; DALFOPRISTIN; ERYTHROMYCIN; LINCOMYCIN; LINCOSAMIDE; MACROLIDE; METHYLTRANSFERASE; QUINUPRISTIN; STREPTOGRAMIN; VIRGINIAMYCIN M;

ANTIBIOTIC RESISTANCE; ARTICLE; BACILLUS SUBTILIS; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; BORRELIA BURGDORFERI; CONTROLLED STUDY; CULTURE MEDIUM; DRUG INACTIVATION; ENTEROCOCCUS FAECALIS; LYME DISEASE; MATING; NONHUMAN; PRIORITY JOURNAL; RIBOSOME; SPIROCHETE;

EID: 33646148260     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2005.11.019     Document Type: Article

References (59)

1. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 54 38 (2005) 949-980
2. Berger B.W. Current aspects of Lyme disease and other Borrelia burgdorferi infections. Dermatol Clin 15 (1997) 247-255
3. Agger W.A., Callister S.M., and Jobe D.A. In vitro susceptibilities of Borrelia burgdorferi to five oral cephalosporins and ceftriaxone. Antimicrob Agents Chemother 36 (1992) 1788-1790
4. Berger B.W. Treatment of erythema chronicum migrans of Lyme disease. Ann N Y Acad Sci 539 (1988) 346-351
5. Dattwyler R.J., Halperin J.J., Pass H., and Luft B.J. Ceftriaxone as effective therapy in refractory Lyme disease. J Infect Dis 155 (1987) 1322-1325
6. Dattwyler R.J., Halperin J.J., Volkman D.J., and Luft B.J. Treatment of late Lyme borreliosis-randomised comparison of ceftriaxone and penicillin. Lancet 1 (1988) 1191-1194
7. Johnson R.C. Isolation techniques for spirochetes and their sensitivity to antibiotics in vitro and in vivo. Rev Infect Dis 11 Suppl. 6 (1989) S1505-S1510
8. Johnson R.C., Kodner C., and Russell M. In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents. Antimicrob Agents Chemother 31 (1987) 164-167
9. Johnson S.E., Klein G.C., Schmid G.P., and Feeley J.C. Susceptibility of the Lyme disease spirochete to seven antimicrobial agents. Yale J Biol Med 57 (1984) 549-553
10. Preac-Mursic V., Wilske B., and Schierz G. European Borrelia burgdorferi isolated from humans and ticks: culture conditions and antibiotic susceptibility. Zentralbl Bakteriol Mikrobiol Hyg [A] 263 (1986) 112-118
11. Wretlind B., Johnson R.C., Hansen K., and Preac-Mursic V. Antibiotic susceptibility of Borrelia burgdorferi in vitro and in animal models. Scand J Infect Dis Suppl 77 (1991) 143-144
12. Dattwyler R.J., Grunwaldt E., and Luft B.J. Clarithromycin in treatment of early Lyme disease: a pilot study. Antimicrob Agents Chemother 40 (1996) 468-469
13. Terekhova D., Sartakova M.L., Wormser G.P., Schwartz I., and Cabello F.C. Erythromycin resistance in Borrelia burgdorferi. Antimicrob Agents Chemother 46 (2002) 3637-3640
14. Eggers C.H., Kimmel B.J., Bono J.L., Elias A.F., Rosa P., and Samuels D.S. Transduction by phiBB-1, a bacteriophage of Borrelia burgdorferi. J Bacteriol 183 (2001) 4771-4778
15. Zhang J.R., Hardham J.M., Barbour A.G., and Norris S.J. Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell 89 (1997) 275-285
16. Arthur M., and Courvalin P. Contribution of two different mechanisms to erythromycin resistance in Escherichia coli. Antimicrob Agents Chemother 30 (1986) 694-700
17. Arthur M., Autissier D., and Courvalin P. Analysis of the nucleotide sequence of the ereB gene encoding the erythromycin esterase type II. Nucleic Acids Res 14 (1986) 4987-4999
18. Yanisch-Perron C., Vieira J., and Messing J. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33 (1985) 103-119
19. Jacob A.E., and Hobbs S.J. Conjugal transfer of plasmid-borne multiple antibiotic resistance in Streptococcus faecalis var. zymogenes. J Bacteriol 117 (1974) 360-372
20. Yagi Y., and Clewell D.B. Recombination-deficient mutant of Streptococcus faecalis. J Bacteriol 143 (1980) 966-970
21. Franke A.E., and Clewell D.B. Evidence for a chromosome-borne resistance transposon (Tn916) in Streptococcus faecalis that is capable of 'conjugal' transfer in the absence of a conjugative plasmid. J Bacteriol 145 (1981) 494-502
22. Trieu-Cuot P., Carlier C., Poyart-Salmeron C., and Courvalin P. A pair of mobilizable shuttle vectors conferring resistance to spectinomycin for molecular cloning in Escherichia coli and in gram-positive bacteria. Nucleic Acids Res 18 (1990) 4296
23. Dunny G., Funk C., and Adsit J. Direct stimulation of the transfer of antibiotic resistance by sex pheromones in Streptococcus faecalis. Plasmid 6 (1981) 270-278
24. Youngman P., Perkins J.B., and Losick R. Construction of a cloning site near one end of Tn917 into which foreign DNA may be inserted without affecting transposition in Bacillus subtilis or expression of the transposon-borne erm gene. Plasmid 12 (1984) 1-9
25. Dubnau D., Davidoff-Abelson R., Scher B., and Cirigliano C. Fate of transforming deoxyribonucleic acid after uptake by competent Bacillus subtilis: phenotypic characterization of radiation-sensitive recombination-deficient mutants. J Bacteriol 114 (1973) 273-286
26. Sutcliffe J., Tait-Kamradt A., and Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother 40 (1996) 1817-1824
27. Barbour A.G. Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med 57 (1984) 521-525
28. Samuels D.S., Mach K.E., and Garon C.F. Genetic transformation of the Lyme disease agent Borrelia burgdorferi with coumarin-resistant gyrB. J Bacteriol 176 (1994) 6045-6049
29. Clancy J., Dib-Hajj F., Petitpas J.W., and Yuan W. Cloning and characterization of a novel macrolide efflux gene, mreA, from Streptococcus agalactiae. Antimicrob Agents Chemother 41 (1997) 2719-2723
30. Goldman R.C., Zakula D., Flamm R., Beyer J., and Capobianco J. Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes. Antimicrob Agents Chemother 38 (1994) 1496-1500
31. Whitaker J.R., and Granum P.E. An absolute method for protein determination based on difference in absorbance at 235 and 280 nm. Anal Biochem 109 (1980) 156-159
32. Sutcliffe J., Grebe T., Tait-Kamradt A., and Wondrack L. Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 40 (1996) 2562-2566
33. Turabelidze D., Kotetishvili M., Kreger A., Morris Jr. J.G., and Sulakvelidze A. Improved pulsed-field gel electrophoresis for typing vancomycin-resistant enterococci. J Clin Microbiol 38 (2000) 4242-4245
34. Preac-Mursic V., Wilske B., Schierz G., Suss E., and Gross B. Comparative antimicrobial activity of the new macrolides against Borrelia burgdorferi. Eur J Clin Microbiol Infect Dis 8 (1989) 651-653
35. Posey J.E., and Gherardini F.C. Lack of a role for iron in the Lyme disease pathogen. Science 288 (2000) 1651-1653
36. Clewell D.B. Bacterial conjugation. 1st ed. (1993), Plenum Press, New York, NY
37. Fraser C.M., Casjens S., Huang W.M., et al. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390 (1997) 580-586
38. Roberts M.C. Resistance to macrolide, lincosamide, streptogramin, ketolide, and oxazolidinone antibiotics. Mol Biotechnol 28 (2004) 47-62
39. Allignet J., Aubert S., Morvan A., and El Solh N. Distribution of genes encoding resistance to streptogramin A and related compounds among staphylococci resistant to these antibiotics. Antimicrob Agents Chemother 40 (1996) 2523-2528
40. Hamilton-Miller J.M., and Shah S. Patterns of phenotypic resistance to the macrolide-lincosamide-ketolide-streptogramin group of antibiotics in staphylococci. J Antimicrob Chemother 46 (2000) 941-949
41. Wondrack L., Massa M., Yang B.V., and Sutcliffe J. Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides. Antimicrob Agents Chemother 40 (1996) 992-998
42. Hagman K.E., Pan W., Spratt B.G., Balthazar J.T., Judd R.C., and Shafer W.M. Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents is modulated by the mtrRCDE efflux system. Microbiology 141 (1995) 611-622
43. Poole K., Krebes K., McNally C., and Neshat S. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J Bacteriol 175 (1993) 7363-7372
44. Kobayashi N., Nishino K., and Yamaguchi A. Novel macrolide-specific ABC-type efflux transporter in Escherichia coli. J Bacteriol 183 (2001) 5639-5644
45. Roberts M.C., Sutcliffe J., Courvalin P., Jensen L.B., Rood J., and Seppala H. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother 43 (1999) 2823-2830
46. Weisblum B. Macrolide resistance. Drug Resist Updat 1 (1998) 29-41
47. Nagai K., Appelbaum P.C., Davies T.A., et al. Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 pneumococci from 10 central and Eastern European countries. Antimicrob Agents Chemother 46 (2002) 371-377
48. Pihlajamaki M., Kataja J., Seppala H., et al. Ribosomal mutations in Streptococcus pneumoniae clinical isolates. Antimicrob Agents Chemother 46 (2002) 654-658
49. Tait-Kamradt A., Davies T., Appelbaum P.C., et al. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America. Antimicrob Agents Chemother 44 (2000) 3395-3401
50. Tait-Kamradt A., Davies T., Cronan M., Jacobs M.R., Appelbaum P.C., and Sutcliffe J. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrob Agents Chemother 44 (2000) 2118-2125
51. Burrus V., Pavlovic G., Decaris B., and Guedon G. Conjugative transposons: the tip of the iceberg. Mol Microbiol 46 (2002) 601-610
52. Clewell D.B. Bacterial sex pheromone-induced plasmid transfer. Cell 73 (1993) 9-12
53. Osborn A.M., and Boltner D. When phage, plasmids, and transposons collide: genomic islands, and conjugative- and mobilizable-transposons as a mosaic continuum. Plasmid 48 (2002) 202-212
54. Clewell D.B., and Flannigan S.E. The conjugative transposons of gram-positive bacteria. In: Clewell D.B. (Ed). Bacterial conjugation (1993), Plenum Press, New York, NY 369-393
55. Hochhut B., and Waldor M.K. Site-specific integration of the conjugal Vibrio cholerae SXT element into prfC. Mol Microbiol 32 (1999) 99-110
56. Calcutt M.J., Lewis M.S., and Wise K.S. Molecular genetic analysis of ICEF, an integrative conjugal element that is present as a repetitive sequence in the chromosome of Mycoplasma fermentans PG18. J Bacteriol 184 (2002) 6929-6941
57. Waldor M.K., Tschape H., and Mekalanos J.J. A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139. J Bacteriol 178 (1996) 4157-4165
58. Le Bouguenec C., Horaud T., Bieth G., Colimon R., and Dauguet C. Translocation of antibiotic resistance markers of a plasmid-free Streptococcus pyogenes (group A) strain into different streptococcal hemolysin plasmids. Mol Gen Genet 194 (1984) 377-387
59. Fujimoto S., Tomita H., Wakamatsu E., Tanimoto K., and Ike Y. Physical mapping of the conjugative bacteriocin plasmid pPD1 of Enterococcus faecalis and identification of the determinant related to the pheromone response. J Bacteriol 177 (1995) 5574-5581